FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutics, specifically to a composition and use thereof for treating inflammatory cystitis, a storage and introduction device, for instillation into the urogenital region, a kit in the form of an instillation system for instillation into the urogenital region. Composition contains effective amounts of chondroitin sulphate or a physiologically compatible salt of chondroitin sulphate, hyaluronic acid or a physiologically compatible hyaluronic acid salt, a dihydrophosphate/monohydrophosphate buffer system in weight ratio of dihydrogen phosphate to monohydrogen phosphate in range of 1:5 to 1:25, physiologically compatible electrolyte, wherein the pH of the composition ranges from 6.1 to 7.9. Device represents a syringe containing a composition for treating cystitis. Kit contains a device for storage and introduction and an instillation device suitable for connection to a device for storage and introduction.
EFFECT: group of inventions provides creating a composition with high storage stability, having high effectiveness in treating inflammatory cystitis.
9 cl, 19 tbl, 3 ex
